Skip to main content
BKYI
NASDAQ Technology

BIO-key 获得 104 万美元扩展生物识别许可，提升财务前景

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
9
Price
$0.66
Mkt Cap
$7.154M
52W Low
$0.509
52W High
$1.97
Market data snapshot near publication time

summarizeSummary

BIO-key International (BKYI) 宣布与一家外国零售银行续签了一份重大扩展许可协议，价值 104 万美元，该银行是其 2015 年的客户。该续约代表着与去年相比增加了 30%，并支持银行为 3 亿多客户提供服务。对于一家市值约为 700 万美元的公司来说，这份合同具有高度的物质性，表明了强大的客户留存率和在关键金融领域的增长。该公司还报告了 270 万美元的年末现金储备，称其拥有足够的现金和预期的资金流来为其增长计划提供内部资金。投资者将密切关注进一步的大规模部署和持续的财务稳定性，当公司执行其增长战略时。

在该公告发布时，BKYI的交易价格为$0.66，交易所为NASDAQ，所属行业为Technology，市值约为$715.4万。 52周交易区间为$0.51至$1.97。 这则新闻被评估为积极市场情绪，重要性评分为9/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed BKYI - Latest Insights

BKYI
Apr 29, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key International Finalizes 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance
Sentiment: Negative
View Wiseek Article
BKYI
Apr 24, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Stockholders Approve Reverse Stock Split to Address Nasdaq Compliance
Sentiment: Neutral
View Wiseek Article
BKYI
Apr 22, 2026, 4:45 PM EDT
Source: GlobeNewswire
Importance Score:
8
BIO-key Receives Nasdaq Non-Compliance Notice for Delayed 10-K Filing
Sentiment: Negative
View Wiseek Article
BKYI
Apr 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Projects 50% H1 Revenue Growth and Profitability Turnaround
Sentiment: Positive
View Wiseek Article
BKYI
Apr 16, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
BIO-key Forecasts 50% H1 Revenue Surge, Projects Positive Net Income
Sentiment: Positive
View Wiseek Article
BKYI
Mar 31, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Reports Strong Cash Position and Positive 2026 Outlook Despite Q4 EPS Miss
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 31, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
BIO-key Reports Q4 Loss of 19 Cents Per Share, Significantly Missing Estimates
Sentiment: Negative
View Wiseek Article
BKYI
Mar 27, 2026, 9:51 AM EDT
Source: Reuters
Importance Score:
7
BIO-Key International Forecasts 7-Cent Loss Per Share, Revenue Expected to Surge 50%
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 16, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
7
BIO-key Files Definitive Proxy for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article
BKYI
Mar 06, 2026, 5:00 PM EST
Filing Type: PRE 14A
Importance Score:
8
BIO-key Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article